Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor
- 1 January 1994
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 297 (1) , 131-136
- https://doi.org/10.1042/bj2970131
Abstract
The inhibition equilibrium and kinetics of association and dissociation of the binding of three types of recombinant tissue factor pathway inhibitor (TFPI), namely full-length TFPI, C-terminal-truncated TFPI, and TFPI without the third Kunitz domain (TFPI1-161), to factor Xa have been measured. Formation and dissociation of the complexes were monitored by continuous measurement of the changes in the rate of hydrolysis of a peptidyl-p-nitroanilide substrate. Progress curves of product formation were fitted to a set of equations describing a one-step bimolecular inhibitory reaction in the presence of a competing substrate. For full-length TFPI the rate constants of association (kon) and dissociation (koff) were (5.1 +/- 0.7) x 10(6) M-1.s-1 and (2.6 +/- 0.9) x 10(-4)s-1 respectively. Thus, although the inhibition constant (50 pM) is far below the plasma concentration (2.5 nM) of TFPI, the half-time for transition to equilibrium in plasma is rather long (66s). The truncated forms of TFPI differ in that they have a 4-fold lower kon value but a similar dissociation rate constant. Therefore the inhibition constant, Ki, is 4-fold higher (0.2 nM) and the half-time to achieve equilibrium is prolonged to 250 s. The kon values of full-length and C-terminal-truncated TFPI, but not that of TFPI1-161, were found to decrease with increasing ionic strength.Keywords
This publication has 20 references indexed in Scilit:
- THE LIMITED IMPORTANCE OF FACTOR-XA INHIBITION TO THE ANTICOAGULANT PROPERTY OF HEPARIN IN THROMBOPLASTIN-ACTIVATED PLASMA1988
- Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.Journal of Biological Chemistry, 1988
- THE LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR THAT INHIBITS THE FACTOR-VII-TISSUE FACTOR COMPLEX ALSO INHIBITS FACTOR XA - INSIGHT INTO ITS POSSIBLE MECHANISM OF ACTION1988
- Tissue factor and hemostasis.1988
- The Behavior and Significance of Slow‐Binding Enzyme InhibitorsPublished by Wiley ,1988
- 1-Aminocyclopropanephosphonate: time-dependent inactivation of 1-aminocyclopropanecarboxylate deaminase and Bacillus stearothermophilus alanine racemase by slow dissociation behaviorBiochemistry, 1987
- STUDIES OF A MECHANISM INHIBITING THE INITIATION OF THE EXTRINSIC PATHWAY OF COAGULATION1987
- CHARACTERIZATION OF THE INHIBITION OF TISSUE FACTOR IN SERUM1987
- Protein Inhibitors of ProteinasesAnnual Review of Biochemistry, 1980
- Tight-binding inhibitors—IBiochemical Pharmacology, 1975